• Home
  • About us
  • Log-In
  • Join Us
  • Sitemap
  • Recruit
Á¦Ç°/½ÇÇè Q&A
ÀÚÁÖ¹¯´ÂÁú¹®
ÀÚÀ¯°Ô½ÃÆÇ
½ÇÇè±â¹ý
ÀÚ·á½Åû
³í¹®ÀÚ·á
Ŭ·¹ÀÓ Á¢¼ö
±â±â A/S Á¢¼ö
Ŭ·¹ÀÓ ÁøÇàÁ¶È¸
 Á¦Ç°¾È³»  ¸é¿ªÇР  Cell Biology  Actin/Tubulin Research

G-switch¢â Activators and Inhibitors

Rho family proteins°ú pathwaysÀÇ Å¸°ÙÀ» ¼±ÅÃÀûÀ¸·Î ÀÛ¿ëÇÏ´Â Activators¿Í Inhibitors¸¦ ¼Ò°³ÇÕ´Ï´Ù.

Cytoskeleton
Á¦Ç° ¹®ÀÇÇϱâ
ÀμâÇϱâ
    Ư¡
  • endogenous Rho family membersÀÇ °­·ÂÇÑ(5~10¹è) activatorÀÔ´Ï´Ù.
  • Ÿ°Ù ´Ü¹éÁúÀÇ over-expressionÀ̳ª knockdown¿¡ ÀÇÁ¸ÇÏ´Â ±âÁ¸ ¹æ¹ý°ú´Â ´Þ¸® G-switch¢âÀÇ ½Ã¾àÀº ¹ÝÀÀÀ» »ý¼ºÇÏ´Â ±âȸ¸¦ ÃÖÀûÈ­½ÃÄÑÁÖ°í, 2-4½Ã°£ ¾È¿¡ activationµË´Ï´Ù.
  • multiple cell type¿¡µµ È¿°úÀûÀÔ´Ï´Ù.
    Àû¿ë
    Dose-dependent activation of RhoA in Swiss 3T3 cells using CN03.
    Dose-dependent activation of RhoA in Swiss 3T3 cells using CN03.
    Actin cytoskeleton morphological changes induced by CN03 treatment of Swiss 3T3 cells.
    Actin cytoskeleton morphological changes induced by CN03 treatment of Swiss 3T3 cells. Swiss 3T3 fibroblasts plated on glass coverslips, grown for 2 days in DMEM plus 10% FBS, serum starved for 24 h in media containing 1% FBS followed by 24 h in serum free media. Cells were treated with a buffer control (A) or 1 u/ml CN03 for 2 h at 37¡ÆC/5% CO2. Cells were then fixed, stained with Acti-stain¢â 488 phalloidin (Cat.#PHDG1), and visualized by fluorescence microscopy. Images were taken at a magnification of 40x. The control cells (A) exhibited mainly edge ruffling, some lamellipodia and very few stress fibers, whereas treatment with CN03 (B) resulted in the development of abundant stress fibers with some edge ruffling. Under similar conditions, RhoA was activated ~10-fold as determined using the RhoA G-LISA¢ç activation assay (Cat.# BK124).
ÁÖ¹®Á¤º¸(Ordering Information)
CATNUM PRODUCT SIZE
CT03-AC3 transferase protein1 x 25ug
CT03-BC3 transferase protein2 x 25ug
CT03-CC3 transferase protein4 x 25ug
CN02-BRac and Cdc42 Activator20 x 20 units
CN02-ARac/Cdc42 Activator II5 x 10 units
CN01-ARho Activator I5 x 10 units
CN01-BRho Activator I20 x 20 units
CN03-BRho Activator II5 x 20 ug
CN03-ARho Activator II1 x 20 ug
CT04-ARho Inhibitor I1 x 20ug
CT04-BRho Inhibitor I5 x 20ug
CT04-CRho Inhibitor I20 x 20ug
CN06-BRho Pathway Inhibitor I - Rho kinase (ROCK) inhibitor Y-2763220 x 10 U
CN06-ARho Pathway Inhibitor I - Rho kinase (ROCK) inhibitor Y-276325 x 10 U
CN04-BRho/Rac/Cdc42 Activator I5 x 20 ug
CN04-ARho/Rac/Cdc42 Activator I1 x 20 ug